Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation' - video Dailymotion

last year

Jim Cramer has expressed his confidence in Eli Lilly, LLY, citing the company’s diverse drug portfolio and the recent endorsement of its Alzheimer’s treatment by FDA advisors.

Category

Recommended

Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation

Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced Portfolio: 'I'm Not Telling You To Relax'

Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock

Jim Cramer Says Investors Should Check Share Count Before Buying A Stock: 'You Want A Management That Agrees With You'

Warren Buffett's Berkshire Hathaway, Elon Musk's Tesla And Eli Lilly Could Be Next Trillion-Dollar Companies After Nvidia's Rapid Ascension: Jim Cramer

Jim Cramer Likes Reddit Very Much, Recommends Nvidia Over Super Micro Computer

From Boeing To Nike, Jim Cramer Spotlights Dow's Biggest Q1 Flops: 'Nothing Pristine About This List'

Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows

Jim Cramer Advises Investors Not To Treat Stocks Like Casino: 'Don't Just Gamble On Stocks For The Excitement Of It - That Is Foolish'

Jim Cramer Sees Nvidia As Going 'From Star Of The Show To Being The Goat Of The Game'

Jim Cramer Admits Palantir CEO Alex Karp's 'Insanity Is Growing On Me' After Q4 Earnings Call: 'Narrative Is Compelling'

Jim Cramer Advocates For Investment In Lockheed Martin, Raytheon And Other Defense Stocks Amid US Arms Stockpile Rebuilding

Jim Cramer: 'Nothing Terrific' About GitLab, But Rocket? Time To 'Ka-Ching, Ka-Ching'

Charlie Munger Revealed What Was Left On His Bucket List Before He Died

Jim Cramer Says Lululemon 'May Have Bottomed' After Nearly 50% Drop This Year, Strongly Confident About Dell As Stock Surges Over 3% In After-Hours Trading

Jim Cramer Reflects On Nvidia's Success After Shares Hit Record High On Thursday: 'Do Opposite Of Everything That Captures Conventional Wisdom'

Jim Cramer Says Mark Zuckerberg Has 'Your Brain' As Meta Pours Billions Into Global Domination Strategy

Jim Cramer Tries To Quell Investor Fears Amid Nvidia Selloff: 'If You Have A Market That's Been Driven By A Handful Of Stocks…'

Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition

Why Is The Fed Still So Aggressive? - Jeremy Schwartz, Chief Investment Officer at WisdomTree

GameStop Rockets As Roaring Kitty Returns To X: What Does His Tweet Signal Ahead Of Q3 Earnings?

Walgreens Agrees To $100 Million Settlement Over Alleged Deceptive Pricing Of Generic Drugs

Are Housing Stocks Pointing Towards A Recession? - $TOL

Jim Cramer Likes Palantir, Recommends Pioneer Natural Resources: 'I Want You To Ka-Ching, Ka-Ching'

Two Top Executives Resign as Investigation Links Deaths to Kobayashi Pharmaceutical's Rice Products